İpek Eroğlu
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Advancements in Transdermal Drug Delivery 7
- Advanced Drug Delivery Systems 5
-
- Nanoparticle-Based Drug Delivery 5
- Electrospun Nanofibers in Biomedical Applications 3
- Co-authors
- Kezban Ulubayram (11 shared papers)Özgen Özer (5 shared papers)Sakine Tuncay Tanrıverdi (5 shared papers)Semih Çalamak (3 shared papers)Reza Shahbazi (3 shared papers)Evren Gökçe (4 shared papers)Merve Gültekinoğlu (4 shared papers)Göksel Gökçe (2 shared papers)
- Journals
- Journal of Liposome Research (3 papers)International Journal of Pharmaceutics (2 papers)Journal of drug targeting (2 papers)AAPS PharmSciTech (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
İpek Eroğlu
21 papers receiving 609 citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 139
- Rehabilitation 120
- Biomaterials 242
- Geriatrics and Gerontology 30
- Dermatology 61
Countries citing papers authored by İpek Eroğlu
This map shows the geographic impact of İpek Eroğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İpek Eroğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İpek Eroğlu more than expected).
Fields of papers citing papers by İpek Eroğlu
This network shows the impact of papers produced by İpek Eroğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İpek Eroğlu. The network helps show where İpek Eroğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside İpek Eroğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 76 | |
| 2 | 2015 | 73 | |
| 3 | 2019 | 72 | |
| 4 | 2019 | 56 | |
| 5 | 2014 | 54 | |
| 6 | 2014 | 52 | |
| 7 | 2017 | 47 | |
| 8 | 2020 | 37 | |
| 9 | 2019 | 36 | |
| 10 | 2018 | 30 | |
| 11 | 2019 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 6 | |
| 17 | 2020 | 5 | |
| 18 | 2024 | 5 | |
| 19 | Chitosan: Manufacture, Properties and Usage | 2010 | 4 |
| 20 | 2024 | 3 |
About İpek Eroğlu
İpek Eroğlu is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Dermatology and Rehabilitation, having authored 23 papers that have together received 622 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (5 papers), Advanced Drug Delivery Systems (5 papers), Wound Healing and Treatments (3 papers), Microencapsulation and Drying Processes (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers) and Antimicrobial agents and applications (2 papers). The work is most often cited by research in Pharmaceutical Science (139 citations), Rehabilitation (120 citations), Biomaterials (242 citations), Geriatrics and Gerontology (30 citations) and Dermatology (61 citations). İpek Eroğlu has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Kezban Ulubayram, Özgen Özer, Sakine Tuncay Tanrıverdi, Semih Çalamak, Reza Shahbazi, Evren Gökçe, Merve Gültekinoğlu, Göksel Gökçe, Nicolas Tsapis and Işıl Tekmen. Their work appears in journals such as Journal of Liposome Research, International Journal of Pharmaceutics, Journal of drug targeting, AAPS PharmSciTech and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.